IDEX Biometrics ASA
IDXAF
$0.20
$0.10100.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -87.82% | -82.54% | -79.73% | -72.47% | -53.36% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -87.82% | -82.54% | -79.73% | -72.47% | -53.36% |
| Cost of Revenue | -41.48% | -52.55% | -56.90% | -53.96% | -35.44% |
| Gross Profit | -758.27% | -2,566.67% | -462.66% | -125.82% | -111.46% |
| SG&A Expenses | -59.63% | -49.89% | -38.50% | -39.51% | -34.91% |
| Depreciation & Amortization | -44.69% | 35.54% | 53.94% | 11.54% | 70.55% |
| Other Operating Expenses | -16.45% | -20.56% | -16.64% | -21.63% | -7.02% |
| Total Operating Expenses | -37.42% | -31.54% | -26.59% | -31.96% | -24.14% |
| Operating Income | 32.82% | 24.97% | 18.40% | 25.24% | 19.54% |
| Income Before Tax | 63.63% | 46.47% | 45.32% | 44.28% | 20.02% |
| Income Tax Expenses | -1,458.33% | -490.00% | -700.00% | 125.76% | 119.67% |
| Earnings from Continuing Operations | 64.33% | 46.91% | 45.74% | 44.09% | 19.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 64.33% | 46.91% | 45.74% | 44.09% | 19.82% |
| EBIT | 32.82% | 24.97% | 18.40% | 25.24% | 19.54% |
| EBITDA | 29.94% | 27.84% | 21.47% | 28.90% | 23.48% |
| EPS Basic | 90.28% | 66.85% | 56.68% | 48.06% | 34.93% |
| Normalized Basic EPS | 88.72% | 65.44% | 50.83% | 42.75% | 35.06% |
| EPS Diluted | 90.72% | 68.65% | 58.01% | 49.72% | 32.33% |
| Normalized Diluted EPS | 88.70% | 65.33% | 50.65% | 42.64% | 35.01% |
| Average Basic Shares Outstanding | 317.42% | 81.28% | 36.13% | 9.69% | 15.40% |
| Average Diluted Shares Outstanding | 316.33% | 80.77% | 35.68% | 9.53% | 15.37% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |